Search

Author/Creator Ponniah, Sathibalan

1. Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines. (February 2011)

Authors:
Benavides, Linda C; Sears, Alan K; Gates, Jeremy D; Clifton, Guy T; Clive, Kevin S; Carmichael, Mark G; Holmes, Jarrod P; Mittendorf, Elizabeth A; Ponniah, Sathibalan; Peoples, George E
Journal:
Expert review of vaccines
Issue:
Volume 10:Number 2(2011)
Page Start:
201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine. (6th November 2014)

Authors:
Greene, Julia; Schneble, Erika; Martin, Jonathan; Flores, Maddie; Trappey, Alfred; Berry, John; Vreeland, Timothy; Hale, Diane; Clifton, Guy; Perez, Sonia A; Papamichail, Michael; Peoples, George; Mittendorf, Elizabeth; Ponniah, Sathibalan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients. Issue 1 (2nd January 2019)

Authors:
Chai, San Jiun; Fong, Sammuel Chee Yong; Gan, Chai Phei; Pua, Kin Choo; Lim, Paul Vey Hong; Lau, Shin Hin; Zain, Rosnah Binti; Abraham, Thomas; Ismail, Siti Mazlipah; Abdul Rahman, Zainal Ariff; Ponniah, Sathibalan; Patel, Vyomesh; Cheong, Sok Ching; Lim, Kue Peng
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 15:Issue 1(2019)
Page Start:
167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients. (7th November 2013)

Authors:
Berry, John S; Schneble, Erika J; Trappey, Alfred F; Vreeland, Timothy J; Clifton, Guy T; Hale, Diane F; Sears, Alan K; Ponniah, Sathibalan; Mittendorf, Elizabeth A; Peoples, George E
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence. (6th November 2014)

Authors:
Greene, Julia; Schneble, Erika; Berry, John; Trappey, Alfred; Vreeland, Timothy; Clifton, Guy; McGuire, William; Maxwell, George; Ponniah, Sathibalan; Peoples, George
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response. (May 2014)

Authors:
Schneble, Erika J; Berry, John S; Trappey, Francois A; Clifton, Guy T; Ponniah, Sathibalan; Mittendorf, Elizabeth; Peoples, George E
Journal:
Immunotherapy
Issue:
Volume 6:Number 5(2014:May)
Page Start:
519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients. (7th November 2013)

Authors:
Schneble, Erika J; Berry, John S; Trappey, Alfred F; Vreeland, Timothy J; Hale, Diane F; Sears, Alan K; Clifton, Guy T; Ponniah, Sathibalan; Shumway, Nathan M; Mittendorf, Elizabeth A; Peoples, George E
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗